Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreActive in the last 2 years

Debra T. Silverman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8894-0301; OpenAlex author ID A5055734126, A5158600715; NIH RePORTER profile ID 6569799. Sources: OpenAlex.

Their work

Papers
34 (first author 2, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
70
Papers, trials and grants by year

2011: 4 papers · 2012: 5 papers · 2013: 2 papers · 2014: 5 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 4 papers · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper, 1 grant · 2026: 4 papers

Papers 34

  1. Long-term exposure to outdoor air pollutants and risk of pancreatic cancer in a large prospective U.S.-based cohort. Co-author DOI 10.1038/s41370-026-00929-9↗
  2. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  3. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  4. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  5. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  6. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  7. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  8. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  9. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  10. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  11. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  12. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  13. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  14. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  15. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  16. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking? Co-author DOI 10.1158/1055-9965.epi-16-0891↗
  17. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  18. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. Co-author DOI 10.1093/aje/kwv041↗
  19. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Co-author DOI 10.1007/s10552-014-0409-z↗
  20. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  21. Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Co-author DOI 10.1093/annonc/mdu019↗
  22. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  23. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Co-author DOI 10.1158/1055-9965.epi-13-1359↗
  24. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  25. Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Last author DOI 10.3945/ajcn.113.058123↗
  26. Occupational risk factors and pancreatic cancer: a review of recent findings. First author DOI 10.1002/mc.20779↗
  27. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdr120↗
  28. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗
  29. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mds140↗
  30. Pancreatic cancer risk and levels of trace elements. Co-author DOI 10.1136/gutjnl-2011-301086↗
  31. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Last author DOI 10.1007/s10552-010-9686-3↗
  32. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdq613↗
  33. Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Co-author DOI 10.1093/annonc/mdr305↗
  34. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. First author DOI 10.1158/1055-9965.epi-10-1024↗

Grants 1

  1. Cancer Risk in Human Populations ZIACP010136↗

Closest collaborators

The 25 strongest of 70 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mark P. Purdue · 1 shared grant, 2025 · strength 1.07
  2. Rachael Z. Stolzenberg‐Solomon · 8 shared papers, 2011–2026 · strength 0.64
  3. Rena R. Jones · 1 shared paper, 2026 · strength 0.33
  4. Amina Chtourou · 1 shared paper, 2026 · strength 0.33
  5. Paige M. Bracci · 9 shared papers, 2011–2014 · strength 0.22
  6. Demetrius Albanes · 5 shared papers, 2011–2017 · strength 0.22
  7. Michaël Pollak · 4 shared papers, 2011–2017 · strength 0.19
  8. Sara H. Olson · 7 shared papers, 2011–2014 · strength 0.17
  9. Robert C. Kurtz · 7 shared papers, 2011–2014 · strength 0.17
  10. Letícia Nogueira · 3 shared papers, 2014–2017 · strength 0.17
  11. Eric J. Jacobs · 3 shared papers, 2014–2017 · strength 0.17
  12. Elizabeth T. H. Fontham · 7 shared papers, 2011–2014 · strength 0.15
  13. H. Bas Bueno-de-Mesquita · 7 shared papers, 2011–2014 · strength 0.15
  14. Eric J. Duell · 7 shared papers, 2011–2014 · strength 0.15
  15. Ersilia Lucenteforte · 7 shared papers, 2011–2014 · strength 0.15
  16. Patrick Maisonneuve · 7 shared papers, 2011–2014 · strength 0.15
  17. Steve Gallinger · 7 shared papers, 2011–2014 · strength 0.15
  18. Gloria M. Petersen · 7 shared papers, 2011–2014 · strength 0.15
  19. Carlo La Vecchia · 7 shared papers, 2011–2014 · strength 0.15
  20. Stephanie J. Weinstein · 3 shared papers, 2011–2017 · strength 0.15
  21. Jerry Polesel · 6 shared papers, 2011–2014 · strength 0.13
  22. Michelle Cotterchio · 6 shared papers, 2011–2014 · strength 0.13
  23. Parviz Ghadirian · 6 shared papers, 2011–2014 · strength 0.13
  24. Paolo Boffetta · 6 shared papers, 2011–2014 · strength 0.13
  25. Dali Li · 6 shared papers, 2011–2014 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.